Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-24-106620
Filing Date
2024-09-16
Accepted
2024-09-16 09:03:19
Documents
2
Period of Report
2024-09-16

Document Format Files

Seq Description Document Type Size
1 6-K earnings_release_sept_16.htm 6-K 21323
2 EX-99.1 ipa-ex99_1.htm EX-99.1 36565
  Complete submission text file 0000950170-24-106620.txt   58920
Mailing Address 3204-4464 MARKHAM ST. VICTORIA A1 V8Z 7X8
Business Address 3204-4464 MARKHAM ST. VICTORIA A1 V8Z 7X8 6048060626
ImmunoPrecise Antibodies Ltd. (Filer) CIK: 0001715925 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0430
Type: 6-K | Act: 34 | File No.: 001-39530 | Film No.: 241299484
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)